Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 17,501 | N/A | N/A |
| Marketable Securities | 7,386 | N/A | N/A |
| TOTAL | $25,406 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 79 | N/A | N/A |
| Other Non-Current Assets | 20 | 0 | 0 |
| TOTAL | $99 | $N/A | $N/A |
| Total Assets | $25,505 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 542 | 0 | 0 |
| Accrued Expenses | 2,397 | N/A | N/A |
| TOTAL | $2,939 | $N/A | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $41 | $N/A | $N/A |
| Total Liabilities | $2,980 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -25,493 | N/A | N/A |
| Other shareholders' equity | 45,655 | 0 | 0 |
| TOTAL | $22,525 | $N/A | $N/A |
| Total Liabilities And Equity | $25,505 | $0 | $0 |